Symptom Tracking in Assisted Reproductive Technologies

Completed

Conditions studied: Depression Relapse in Women Undergoing Fertility Treatment

In brief

This study assesses risk factors for depressive relapse in women undergoing fertility treatment with histories of major depressive disorder (MDD) or bipolar disorder. The study is focused on the acute risk factors of depressive relapse. The investigators hypothesize that risk for depressive relapse will be greater among women who stop antidepressants compared to those who continue treatment with these agents.

Key facts

Study ID

NCT01746797

Run by

Massachusetts General Hospital

People needed

49

Starts

2012-10-01

Expected to finish

2018-01-16

Last updated by the study team

2018-01-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Have a history of a MDE or bipolar disorder prior to starting fertility treatment.
• Have received consultation around infertility treatment and plan to start fertility treatment.

You may not qualify if…

• Use of corticosteroids within 1 month of enrollment.
• Presence of any endocrine or autoimmune disorder, other than hypothyroidism well-treated for at least 6 months.
• Current episode of depression or mania.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.